6 Recruiting Lung Adenocarcinoma Phase 2 Clinical Trials
Active phase 2 studies for lung adenocarcinoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Lung Adenocarcinoma studiesPhase 2 Studies for Lung Adenocarcinoma
🔵 Active, Not Recruiting Phase2 / Phase3
Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
📍 Veterans Administration Medical Center - Birmingham — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
📍 Providence Hospital — Mobile, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase2
Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer
📍 Keck Medicine of USC Buena Park — Buena Park, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer
📍 Yesenia Calzada — Los Angeles, California
View Study & Checklist ➔